SCHEMBL2403678

SCHEMBL2403678

CCCCCCCCCc1[nH]cc[n+]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.40
GPR84 Q9NQS5 1/20 0.40
ADRA2A P08913 3/20 0.35
ADORA3 P0DMS8 3/20 0.35
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 3/20 0.35
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35
ACHE P22303 2/20 0.35
ESR1 P03372 2/20 0.35
ABCB11 O95342 1/20 0.35
PGR P06401 1/20 0.35
HTR1A P08908 1/20 0.35
DRD1 P21728 1/20 0.35
TBXA2R P21731 1/20 0.35
PTGS1 P23219 1/20 0.35
PDE4A P27815 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627668 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL233861 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL1299806 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL4347828 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL3885723 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL2351436 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL1818170 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL2229126 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL5300868 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2
SCHEMBL3664070 1.00 KCNH2 (0.40) KCNH2GPR84ADRA2AADORA3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010125302-A1 USE OF IONIC LIQUID FOR THE PERMANENT SHAPING OF KERATINIC FIBRES L'OREAL (FR) 2010-11-04 WO claimed
US-7553406-B2 Process for removing polar impurities from hydrocarbons and mixtures of hydrocarbons MERCK PATENT GMBH (DE) 2009-06-30 US claimed
CN-119255857-A Low viscosity metal ion containing liquids 切弗朗菲利浦化学公司 2025-01-03 CN disclosed
WO-2021130434-A1 PIEZOELECTRIC COMPOSITE MATERIALS HAVING IMPROVED PIEZOELECTRIC PROPERTIES COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2021-07-01 WO disclosed
US-10961468-B2 Multi-stage device for reducing environmental contaminates in heavy marine fuel oil Magëmä Technology LLC (US) 2021-03-30 US disclosed
US-10655074-B2 Multi-stage process and device for reducing environmental contaminates in heavy marine fuel oil Mag{hacek over (e)}m{hacek over (a)} Technology LLC (US) 2020-05-19 US disclosed
US-20200095508-A1 Multi-Stage Device for Reducing Environmental Contaminates in Heavy Marine Fuel Oil Magëmä Technology LLC (US) 2020-03-26 US disclosed
US-10099967-B2 Hypergolic salts with borane cluster anions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2018-10-16 US disclosed
US-20140373984-A1 HYPERGOLIC SALTS WITH BORANE CLUSTER ANIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 2014-12-25 US disclosed
US-20140030182-A1 CARBON FILMS PRODUCED FROM IONIC LIQUID CARBON PRECURSORS UT-BATTELLE, LLC (US) 2014-01-30 US disclosed
US-8574534-B2 Carbon films produced from ionic liquid carbon precursors UT-BATTELLE, LLC (US) 2013-11-05 US disclosed
US-20060211096-A1 Enzyme catalysis in the presence of ionic liquids KRAGL UDO 2006-09-21 US disclosed
EP-1332221-B1 ENZYME CATALYSIS IN THE PRESENCE OF IONIC LIQUIDS SOLVENT INNOVATION GMBH (DE) 2006-06-28 EP disclosed
EP-1442001-A2 METHOD FOR ELIMINATING POLARIZABLE IMPURITIES FROM HYDROCARBONS AND HYDROCARBON MIXTURES Solvent Innovation GmbH (DE) 2004-08-04 EP disclosed
US-20040096932-A1 Enzyme catalysis in the presence of ionic liquids KRAGL UDO (DE) 2004-05-20 US disclosed
EP-1332221-A1 ENZYME CATALYSIS IN THE PRESENCE OF IONIC LIQUIDS Solvent Innovation GmbH (DE) 2003-08-06 EP disclosed
WO-2003039719-A2 METHOD FOR SEPARATING SUBSTANCES FROM SOLUTIONS CONTAINING IONIC LIQUIDS BY MEANS OF A MEMBRANE SOLVENT INNOVATION GMBH (DE) 2003-05-15 WO disclosed
WO-2003037835-A2 METHOD FOR ELIMINATING POLARIZABLE IMPURITIES FROM HYDROCARBONS WITH IONIC LIQUIDS SOLVENT INNOVATION GMBH (DE) 2003-05-08 WO disclosed
WO-2002038784-A1 ENZYME CATALYSIS IN THE PRESENCE OF IONIC LIQUIDS SOLVENT INNOVATION GMBH (DE) 2002-05-16 WO disclosed
EP-1205555-A1 Enzymatic catalysis in the presence of ionic liquids Solvent Innovation GmbH (DE) 2002-05-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10099967-B2 Hypergolic salts with borane cluster anions GRN, NOS1, GRIA1 KCNH2 1457/4885GPR84 292/4885ADRA2A 2610/4885
US-20140373984-A1 HYPERGOLIC SALTS WITH BORANE CLUSTER ANIONS GRN, NOS1, GRIA1 KCNH2 1457/4885GPR84 292/4885ADRA2A 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.